Directly observed intermittent short-course chemotherapy in the Kathmandu valley

Onozaki, 1995, Feasibility study of a district tuberculosis control programme with an 8-month short-course chemotherapy regimen utilizing the integrated health service network under field conditions in Nepal, Tubercle Lung Dis, 75, 65, 10.1016/0962-8479(95)90582-0 His Majesty's Government of Nepal, Ministry of Health, National Tuberculosis Centre, Kathmandu: Health Policies & Strategies for National Tuberculosis Control Programme 1994. General Manual, National Tuberculosis Control Programme 1995, Ministry of Health, National TB Centre, Kathmandu. Nkinda, 1984, Developments in the national tuberculosis control programme in Tanzania, Bull Int Union Tuberc, 59, 77 Styblo, 1989, Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries, Rev Infect Dis, 11, 339, 10.1093/clinids/11.Supplement_2.S339 Enarson, 1991, Principles of IUATLD collaborative tuberculosis programmes, Bull Int Union Tuberc Lung Dis, 66, 195 Hong Kong Chest Service/British Medical Research Council, 1982, Controlled trial of 4 three- times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis, 63, 89 Cohn, 1990, A 62-dose 6-months therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost effective regimen, Ann Intern Med, 112, 407, 10.7326/0003-4819-76-3-112-6-407 Prabhaker, 1987, Fully intermittent six-month regimens for pulmonary tuberculosis in South India, Bull Int Union Tuberc Lung Dis, 62, 21 Paramasivan, 1993, Bacteriological investigations for short-course chemotherapy under the tuberculosis programme in two districts of India, Tubercle Lung Dis, 74, 23, 10.1016/0962-8479(93)90064-5 Snider, 1982, Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland, Am Rev Respir Dis, 125, 265 Combs, 1990, USPHS Tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity and acceptability, Ann Intern Med, 112, 397, 10.7326/0003-4819-76-3-112-6-397 Iseman, 1993, Directly observed treatment of tuberculosis: we can't afford not to try it, N Engl J Med, 328, 576, 10.1056/NEJM199302253280811 Weis, 1994, The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis, N Engl J Med, 330, 1179, 10.1056/NEJM199404283301702 Frieden, 1995, The proven advantages of specialized care in the control of TB the New York experience, TB & HIV, 6, 18 Chaulet, 1995, The supply of antituberculosis drugs: price evolution, Tubercle Lung Dis, 76, 261, 10.1016/S0962-8479(05)80015-2 Westaway, 1991, Supervised outpatient treatment of tuberculosis: evaluation of a South African rural programme, Tubercle, 72, 140, 10.1016/0041-3879(91)90041-P